cyproterone acetate has been researched along with Cardiovascular Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J; Tsang, S; Wong, TM; Wu, S | 1 |
| Asscheman, H; Gooren, LJ; Megens, JA; van Kesteren, PJ | 1 |
2 other study(ies) available for cyproterone acetate and Cardiovascular Stroke
| Article | Year |
|---|---|
Testosterone protects rat hearts against ischaemic insults by enhancing the effects of alpha(1)-adrenoceptor stimulation.
Topics: Adrenergic Agonists; Adrenergic Antagonists; Androgen Antagonists; Animals; Arrhythmias, Cardiac; Cell Survival; Cyproterone Acetate; Disease Models, Animal; L-Lactate Dehydrogenase; Male; Myocardial Contraction; Myocardial Infarction; Myocytes, Cardiac; Norepinephrine; Orchiectomy; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Androgen; Reperfusion Injury; Testosterone; Time Factors; Up-Regulation; Ventricular Function, Left | 2008 |
Mortality and morbidity in transsexual subjects treated with cross-sex hormones.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Cyproterone Acetate; Female; Humans; Male; Middle Aged; Morbidity; Myocardial Infarction; Pulmonary Embolism; Retrospective Studies; Suicide; Testosterone; Thromboembolism; Transsexualism | 1997 |